DBV Technologies SA
F:DBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DBV Technologies SA
F:DBV
|
FR |
|
D
|
DaVita Inc
XMUN:TRL
|
US |
|
C
|
Charles Schwab Corp
XMUN:SWG
|
US |
|
B
|
Barrick Gold Corp
XMUN:ABR
|
CA |
|
M
|
Marsh & McLennan Companies Inc
SWB:MSN
|
US |
|
S
|
Starbucks Corp
XMUN:SRB
|
US |
|
Credit Agricole SA
MIL:ACA
|
FR |
|
C
|
CF Industries Holdings Inc
F:C4F
|
US |
|
B
|
Bayerische Motoren Werke AG
XMUN:BMW
|
DE |
|
Klaveness Combination Carriers ASA
F:36K
|
NO |
|
H
|
Hartford Financial Services Group Inc
XMUN:HFF
|
US |
|
R
|
RWE AG
XMUN:RWE
|
DE |
|
A
|
ACADIA Pharmaceuticals Inc
F:DR6
|
US |
|
I
|
IQVIA Holdings Inc
F:QTS
|
US |
|
M
|
Merck & Co Inc
DUS:6MK
|
US |
Bankruptcy Probability
DBV Technologies SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
DBV Technologies SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
DBV Technologies SA
PAR:DBV
|
850.9m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
415B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
155.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
DBV Technologies SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, DBV Technologies SA has total debt of 5.4m USD. This includes both short-term (0 USD) and long-term (5.4m USD) debt.
You can find a full breakdown on its Balance Sheet.
